4//SEC Filing
Horn Howard 4
Accession 0000950170-24-026672
CIK 0001515673other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:23 PM ET
Size
7.7 KB
Accession
0000950170-24-026672
Insider Transaction Report
Form 4
Horn Howard
Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-01+19,400→ 99,766 total - Award
Stock Option (Right to Buy)
2024-03-01+34,200→ 34,200 totalExercise: $53.69Exp: 2034-03-01→ Common Stock (34,200 underlying)
Footnotes (3)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. The amount of securities beneficially owned in column 5 reflects the correction of a typographical error in the Form 4 filed by the Reporting Person on October 10, 2023 (the "October 2023 Form 4"). The accurate number of securities beneficially owned by the Reporting Person in Column 5 of the October 2023 Form 4 is 80,366.
- [F3]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001786335
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 8:23 PM ET
- Size
- 7.7 KB